Kineta Number of Employees 2014-2024 | KANT
Kineta number of employees from 2014 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Kineta Annual Employee Count |
| 2023 |
11 |
| 2022 |
12 |
| 2021 |
41 |
| 2020 |
44 |
| 2019 |
44 |
| 2018 |
49 |
| 2017 |
52 |
| 2016 |
73 |
| 2015 |
43 |
| 2014 |
43 |
| 2013 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
|
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|
